Results 141 to 150 of about 27,373 (254)

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update [PDF]

, 2014
Aletaha, D. (Daniel), Betteridge, N. (Neil), Bijlsma, J.W.J. (Hans), Boers, M. (Maarten), Breedveld, F.C. (Ferdinand), Buch, T. (Thorsten), Burmester, G.R. (Gerd), Buttgereit, F. (Frank), Combe, B. (Bernard), Cutolo, M. (Maurizio), Damjanov, N. (Nemanja), Dougados, M. (Maxime), Emery, P. (Paul), Gaujoux-Viala, C. (Cécile), Gossec, L. (Laure), Hazes, J.M.W. (Mieke), Heijde, D. (Desiree) van der, Kouloumas, M. (Marios), Kvien, T.K. (Tore), Landewé, R.B.M. (Robert), M. de Wit (Maarten), Mariette, X. (Xavier), Nam, N. (Nguyen) van, Pavelka, K. (Karel), Ramiro, S. (Sofia), Riel, P.L.C.M. (Piet) van, Rubbert-Roth, A. (Andrea), Scholte-Voshaar, M. (Marieke), Scott, D.L. (David), Smolen, J.S. (Josef), Sokka-Isler, T. (Tuulikki), Winthrop, K. (Kevin), Wong, J.B. (John)   +32 more
core   +1 more source

Long-Term Effects of Rheumatoid Arthritis Treatments on Bone Mineral Density: 8-Year-Follow-Up Data from Real-World Practice. [PDF]

J Clin Med
Barbaro LE, Bustamente L, Evenor L, Villain A, Vall A, Fabre R, Bailly L, Breuil V, Pradier C, Roux C.   +9 more
europepmc   +1 more source

Janus Kinase Inhibitor Upadacitinib in Elderly-Onset Rheumatoid Arthritis With Hip Osteoarthritis: A Case Report. [PDF]

Am J Case Rep
Sanji Y, Matsushita I, Takahashi E, Fukui M, Kitajima H, Kaneuji A.   +5 more
europepmc   +1 more source

2. Antirheumatic Agents, 2) Biological Agents

Nihon Naika Gakkai Zasshi, 2012
openaire   +2 more sources

Mode of action-specific and cause-specific retention of biologic and targeted synthetic disease-modifying antirheumatic drugs in anti-SS-A antibody-positive rheumatoid arthritis: The ANSWER cohort study. [PDF]

PLoS One
Nishisaka K, Okano T, Imai T, Tsubosaka M, Kamenaga T, Nakano N, Hayashi S, Yamamoto W, Onishi A, Murakami K, Tsujimoto K, Katsushima M, Yoshikawa A, Kotani T, Amuro H, Son Y, Itami T, Nozaki Y, Nose Y, Yamashita M, Shirasugi I, Yamada H, Nishimura K, Ueda Y, Sendo S, Hashimoto M, Kuroda R, Saegusa J.   +27 more
europepmc   +1 more source

Non-Responders to Biologic Disease Modifying Antirheumatic Treatment for Inflammatory Bowel Diseases. [PDF]

Mediators Inflamm
Gadzhanova S, Roughead E.
europepmc   +1 more source

A Causal Association Between Drug Use and Cognitive Impairment: A Two-Sample Mendelian Randomization Study. [PDF]

Brain Behav
Yan B, Chen Z, Yang D.
europepmc   +1 more source

Adoption of new treatment options in non-systemic juvenile idiopathic arthritis (JIA) in clinical practice. [PDF]

Pediatr Rheumatol Online J
Lamers HC, Van Nieuwenhove E, Vastert SJ, Jansen MHA, van Royen-Kerkhof A, Swart JF, de Roock S.   +6 more
europepmc   +1 more source

Juvenile Idiopathic Arthritis Registry at King Abdullah Specialized Children's Hospital (JIAR-KASCH) in Riyadh, Saudi Arabia. [PDF]

Saudi Med J
Alqanatish JT, Almojali AI, Algbaiwi WM, Alqahtani AS, Alrasheed AA, Alnasser LA, Alsuwairi WM.   +6 more
europepmc   +1 more source

Prevalence and risk factors of difficult-to-treat axial spondyloarthritis: Real-life evidence from the BioSTaR database. [PDF]

Clin Rheumatol
Bodur H, Ataman Ş, Yurdakul FG, Gürer G, Akgün K, İnceoğlu LA, Sunar İ, Akgül Ö, Sezer İ, Çapkın E, Rezvani A, Yağcı İ, Duruöz MT, Çay HF, Çevik R, Göğüş F, Kamanlı A, Ecesoy H, Güler T, Şahin N, Cengiz G, Melikoğlu MA.   +21 more
europepmc   +1 more source